Floatz logo

L-Ofloxacin

Pneumococcal Infection

Minsk Scientific-Practical Center for Surgery, Transplantation and HematologySmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Pneumococcal Infection cohort.

Same molecule, other indications

L-Ofloxacin is also rated in:

myelodysplastic syndromeDormant
BB
Indicative ·
68 / 100
View asset →
Febrile NeutropeniaDormant
BB
Indicative ·
68 / 100
View asset →
Pneumococcal PneumoniaDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →